Measuring the infectiousness of persons with HIV-1: Opportunities for preventing sexual HIV-1 transmission

被引:78
作者
Baeten, JM
Overbaugh, J
机构
[1] Univ Washington, Dept Epidemiol, Seattle, WA 98104 USA
[2] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA
关键词
HIV-1; transmission; shedding; infectivity;
D O I
10.2174/1570162033352110
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Methods to reduce sexual transmission of HIV-1 are urgently needed to slow the global HIV-1 epidemic. These methods should include interventions that minimize susceptibility in uninfected populations at risk, as well as interventions that decrease the infectiousness of HIV-1 infected individuals. Surprisingly few interventions to prevent HIV-1 transmission have been targeted at persons who are already infected, although such interventions could have a significant impact on population-wide HIV-1 spread. This review summarizes current knowledge of factors that influence HIV-1 infectiousness, with special attention on the role of genital tract HIV-1 as a surrogate marker of infectiousness. Epidemiologic studies have demonstrated good agreement between factors associated with increased HIV-1 transmission and increased HIV-1 genital tract shedding. Treatment of sexually transmitted diseases and initiation of antiretroviral therapy have been shown to reduce HIV-1 shedding and thus are promising interventions that may reduce HIV-1 transmission. Unresolved issues related to optimal measurement techniques for genital HIV-1, promises and limitations of antiretroviral therapy and vaccines to reduce infectiousness, and other intervention strategies still in development are reviewed.
引用
收藏
页码:69 / 86
页数:18
相关论文
共 197 条
  • [1] AHLGREN DJ, 1990, J ACQ IMMUN DEF SYND, V3, P631
  • [2] A menstrual cycle pattern for cytokine levels exists in HIV-positive women: implication for HIV vaginal and plasma shedding
    Al-Harthi, L
    Kovacs, A
    Coombs, RW
    Reichelderfer, PS
    Wright, DJ
    Cohen, MH
    Cohn, J
    Cu-Uvin, S
    Watts, H
    Lewis, S
    Beckner, S
    Landay, A
    [J]. AIDS, 2001, 15 (12) : 1535 - 1543
  • [3] EFFECTS OF DISEASE STAGE AND ZIDOVUDINE THERAPY ON THE DETECTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN SEMEN
    ANDERSON, DJ
    OBRIEN, TR
    POLITCH, JA
    MARTINEZ, A
    SEAGE, GR
    PADIAN, N
    HORSBURGH, CR
    MAYER, KH
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (20): : 2769 - 2774
  • [4] ANDERSON R M, 1991
  • [5] [Anonymous], 1992, BMJ, V304, P809
  • [6] Ecological and individual level analysis of risk factors for HIV infection in four urban populations in sub-Saharan Africa with different levels of HIV infection
    Auvert, B
    Buvé, A
    Ferry, B
    Caraël, M
    Morison, L
    Lagarde, E
    Robinson, NJ
    Kahindo, M
    Chege, J
    Rutenberg, N
    Musonda, R
    Laourou, M
    Akam, E
    [J]. AIDS, 2001, 15 : S15 - S30
  • [7] MUCOSAL INFECTION OF NEONATAL RHESUS-MONKEYS WITH CELL-FREE SIV
    BABA, TW
    KOCH, J
    MITTLER, ES
    GREENE, M
    WYAND, M
    PENNINCK, D
    RUPRECHT, RM
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (04) : 351 - 357
  • [8] Infection and AIDS in adult macaques after nontraumatic oral exposure to cell-free SIV
    Baba, TW
    Trichel, AM
    An, L
    Liska, V
    Martin, LN
    MurpheyCorb, M
    Ruprecht, RM
    [J]. SCIENCE, 1996, 272 (5267) : 1486 - 1489
  • [9] Vitamin A deficiency and the acute phase response among HIV-1-infected and -uninfected women in Kenya
    Baeten, JM
    McClelland, RS
    Richardson, BA
    Bankson, DD
    Lavreys, L
    Wener, MH
    Overbaugh, J
    Mandaliya, K
    Ndinya-Achola, JO
    Bwayo, JJ
    Kreiss, JK
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 31 (02) : 243 - 249
  • [10] Baeten JM, 2001, J ACQ IMMUN DEF SYND, V26, P360, DOI 10.1097/00126334-200104010-00013